KIORA PHARMACEUTICALS, INC. Convertible Preferred Stock, Shares Issued upon Conversion
KIORA PHARMACEUTICALS, INC. (KPRX) had Convertible Preferred Stock, Shares Issued upon Conversion of 1.36 million shares as of 2018-04-17, per its 10-K filed 2021-03-25.
Discontinued › Notes › Equity › Stockholders' Equity Note › Class of Stock Disclosures
us-gaap:ConvertiblePreferredStockSharesIssuedUponConversion · last filed 2021-03-25
- 2018-04-17: Convertible Preferred Stock, Shares Issued upon Conversion 1.36M shares; Convertible Preferred Stock, Shares Issued upon Conversion as first filed 20.43M shares.
- 2017-06-14: Convertible Preferred Stock, Shares Issued upon Conversion 88.67K shares; Convertible Preferred Stock, Shares Issued upon Conversion as first filed 1.33M shares.
- 2016-06-30: Convertible Preferred Stock, Shares Issued upon Conversion 1.23M shares.
| Period end | Convertible Preferred Stock, Shares Issued upon Conversion | Convertible Preferred Stock, Shares Issued upon Conversion as first filed |
|---|---|---|
| 2018-04-17 | 1.36M shares 10-K · filed 2021-03-25 | 20.43M shares 10-Q · filed 2018-08-03 |
| 2017-06-14 | 88.67K shares 10-K · filed 2020-03-04 | 1.33M shares 10-Q · filed 2017-08-04 |
| 2016-06-30 | 1.23M shares 10-K · filed 2018-03-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |